Oligodendrocytes Engineered With Migratory Proteins as Effective Graft Source for Cell Transplantation in Multiple Sclerosis

Ike C. De La Pena; Mibel Pabon; Sandra Acosta; Paul R. Sanberg; Naoki Tajiri; Yuji Kaneko; Cesar V. Borlongan

doi:10.3727/215517913X674144

Oligodendrocytes Engineered With Migratory Proteins as Effective Graft Source for Cell Transplantation in Multiple Sclerosis

Ike C. De La Pena
, Mibel Pabon
, Sandra Acosta
, Paul R. Sanberg
, Naoki Tajiri
, Yuji Kaneko
, Cesar V. Borlongan

Pharmaceutical and Administrative Sciences

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Cell Medicine
Volume	6
DOIs	https://doi.org/10.3727/215517913X674144
State	Published - Apr 10 2014

Disciplines

Molecular and Cellular Neuroscience
Medical Cell Biology

Access to Document

10.3727/215517913X674144License: Unspecified

OpenUrl availability

Full text

Cite this

@article{e80cfcefacf0481793743578d805468d,

title = "Oligodendrocytes Engineered With Migratory Proteins as Effective Graft Source for Cell Transplantation in Multiple Sclerosis",

author = "\{De La Pena\}, \{Ike C.\} and Mibel Pabon and Sandra Acosta and Sanberg, \{Paul R.\} and Naoki Tajiri and Yuji Kaneko and Borlongan, \{Cesar V.\}",

note = "Multiple sclerosis (MS) is characterized by widespread immunomodulatory demyelination of the central nervous system (CNS), resulting in nerve cell dysfunction. Accordingly, treatment strategies have been centered on immunodulation and remyelination, with the former primarily focused on reducing the pathology rather than enhancing myelin repair, which the latter targets.",

year = "2014",

month = apr,

day = "10",

doi = "10.3727/215517913X674144",

language = "American English",

volume = "6",

journal = "Cell Medicine",

}

TY - JOUR

T1 - Oligodendrocytes Engineered With Migratory Proteins as Effective Graft Source for Cell Transplantation in Multiple Sclerosis

AU - De La Pena, Ike C.

AU - Pabon, Mibel

AU - Acosta, Sandra

AU - Sanberg, Paul R.

AU - Tajiri, Naoki

AU - Kaneko, Yuji

AU - Borlongan, Cesar V.

N1 - Multiple sclerosis (MS) is characterized by widespread immunomodulatory demyelination of the central nervous system (CNS), resulting in nerve cell dysfunction. Accordingly, treatment strategies have been centered on immunodulation and remyelination, with the former primarily focused on reducing the pathology rather than enhancing myelin repair, which the latter targets.

PY - 2014/4/10

Y1 - 2014/4/10

UR - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080202/

U2 - 10.3727/215517913X674144

DO - 10.3727/215517913X674144

M3 - Article

VL - 6

JO - Cell Medicine

JF - Cell Medicine

ER -

Oligodendrocytes Engineered With Migratory Proteins as Effective Graft Source for Cell Transplantation in Multiple Sclerosis

Disciplines

Access to Document

OpenUrl availability

Other files and links

Cite this